Advertisement
Device Sectors
Subscribe to Device Sectors
View Sample

FREE Email Newsletter

Consumer Information on: Propel - P100044

August 19, 2011 9:31 am | by U.S. Food & Drug Administration | News | Comments

The Propel sinus implant is a temporary, self-absorbing implant designed to keep the spaces within and around the sinuses open following sinus surgery. The Propel sinus implant is manufactured from a synthetic material which is absorbed by the body over 4

Nyx Devices' sleep-monitoring shirt attracts $500K

August 19, 2011 7:41 am | by Mass High Tech: The Journal of New England Technology | News | Comments

MIT researchers have developed sleep-monitoring technology in the form of an electronic T-shirt, and now their company, Nyx Devices Inc., is reaping the benefits. The startup announced in a regulatory filing Thursday that it has secured a $500,000 financing via equity and securities.

AHRA 2011: Get 'Er Done: Management Best Practices from the Pros

August 19, 2011 7:39 am | by Diagnostic Imaging | News | Comments

GRAPEVINE, TX -No one's plates are getting any less full these days. So when thrown a new work project, it's best to breathe and strategize, practice management consultants told attendees of the annual AHRA conference this week.

Advertisement

Chindex International, Inc. Announces Participation in Upcoming Investor Conferences

August 19, 2011 6:54 am | by Bio-Medicine.Org | News | Comments

BETHESDA, Md., Aug. 19, 2011 /PRNewswire-Asia/ -- Chindex International, Inc. (NASDAQ: CHDX ), an American health care company providing health care services in China through the operations of United Family Healthcare, a network of private primary care hospitals and affiliated ambulatory...

Valeant Pharmaceuticals Completes Acquisition of Sanitas Group

August 19, 2011 6:50 am | by Bio-Medicine.Org | News | Comments

MISSISSAUGA, Ontario, Aug. 19, 2011 /- Valeant Pharmaceuticals International, Inc. (NYSE: VRX ) (TSX: VRX) announced that effective August 19, 2011, the company completed its previously announced acquisition of AB Sanitas (NASDAQ OMX: SAN1L). About Valeant Valeant Pharmaceuticals...

Verathon® Introduces the Heartscape™ 3D ECG System with 80-Lead Vest in Europe; Technology Provides More Complete Data to Help Diagnose Acute Myocardial Infarction (MI)

August 19, 2011 3:48 am | by Bio-Medicine.Org | News | Comments

BOTHELL, Wash., Aug. 19, 2011 /- Verathon Inc. is pleased to introduce in Europe the Heartscape™ 3D ECG System with 80-lead vest, designed to give Emergency Department (ED) physicians, Interventional Cardiologists, and ED nurses a more complete diagnostic picture by providing a 360...

Nuclea Biotechnologies lands $3M funding

August 18, 2011 8:37 pm | by Mass High Tech: The Journal of New England Technology | News | Comments

Nuclea Biotechnologies LLC, a cancer diagnostics firm in Pittsfield, has rounded up $3 million in an equity offering backed by 28 investors, the company revealed in federal documents.

Heska Retains Hayden IR to Develop Comprehensive Investor Relations Program

August 18, 2011 11:50 am | by Bio-Medicine.Org | News | Comments

LOVELAND, Colo., Aug. 18, 2011 /- Heska Corporation (NASDAQ: HSKA, " Heska " or the "Company"), a provider of advanced veterinary diagnostic and other specialty veterinary products, today announced that it has retained Hayden IR, a national, New York-based investor relations consulting...

Advertisement

Tips for Reducing the Signs of Arthritis in Pets

August 18, 2011 11:42 am | by Bio-Medicine.Org | News | Comments

PLYMOUTH MEETING, Pa., Aug. 18, 2011 /- According to the Arthritis Foundation, arthritis affects one in every five adult dogs in the United States and is one of the most common sources of chronic pain that veterinarians treat. Pet owners can easily be overwhelmed by the variety of...

ConvaTec Healthcare Announces 2011 Second Quarter Earnings Call

August 18, 2011 8:49 am | by Bio-Medicine.Org | News | Comments

SKILLMAN, N.J., Aug. 18, 2011 /- ConvaTec Healthcare today announced that it will report its 2011 second quarter earnings on Tuesday, August 23, 2011. David Johnson, CEO and George Kegler, CFO will host an analyst and investor call at 9:00 AM EDT live via telephone. Questions and answers...

Industry Leaders Hinson and Friel Join Wright Therapy Products

August 18, 2011 8:40 am | by Bio-Medicine.Org | News | Comments

PITTSBURGH, Aug. 18, 2011 /- Wright Therapy Products, Inc. announced today that Michael Hinson has been appointed President and Chief Executive Officer of the company.  The company, based in Oakdale, PA, manufactures and sells pneumatic compression devices targeted for the treatment...

PMA Final Decisions for June 2011

August 18, 2011 6:31 am | by U.S. Food & Drug Administration | News | Comments

These are Premarket Approvals (PMA), Product Development Protocols (PDP), Supplement and Notice Decisions for June 2011.

Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2011 Financial Results

August 18, 2011 5:50 am | by Bio-Medicine.Org | News | Comments

EXTON, Pa., Aug. 18, 2011 /- Kensey Nash Corporation (NASDAQ: KNSY ), a medical device company primarily focused on regenerative medicine for a wide range of medical procedures, today reported the results for its fourth quarter and fiscal year ended June 30, 2011.   Fourth Quarter...

Advertisement

Cardium Announces Receipt of $1.1 Million in Funds from Philips' Acquisition of Innercool Therapies

August 18, 2011 5:50 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Aug. 18, 2011 /- Cardium Therapeutics (NYSE Amex: CXM ) today reported that it had received funds corresponding to the final $1.1 million payment from Royal Philips Electronics in connection with Philips' acquisition of Innercool Therapies from Cardium.  The release of...

REMEDIAL II Trial of PLC's RenalGuard® Article Published in Circulation

August 18, 2011 5:50 am | by Bio-Medicine.Org | News | Comments

MILFORD, Mass., Aug. 18, 2011 /- PLC Systems Inc. (OTCBB: PLCSF), a company focused on innovative medical device technologies, today announced that final results from the REMEDIAL II investigator-sponsored clinical trial of RenalGuard® in Italy have been published on-line in...

Valeant Pharmaceuticals Announces Resignation of Michael Van Every From Valeant's Board of Directors

August 18, 2011 5:48 am | by Bio-Medicine.Org | News | Comments

MISSISSAUGA, Ontario, Aug. 18, 2011 /- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) announced that Michael Van Every has resigned from Valeant's Board of Directors due to health reasons. "We want to thank Michael for his many years of service to the Company, first...

CoLucid Pharmaceuticals Receives Clearance for Investigational New Drug (IND) Application for Lasmiditan for the Treatment of Acute Migraine

August 18, 2011 5:48 am | by Bio-Medicine.Org | News | Comments

DURHAM, N.C., Aug. 18, 2011 /PRNewswire-iReach/ -- Durham, NC, August 18, 2011 /- CoLucid Pharmaceuticals, Inc., a privately held biopharmaceutical company, announced today that it has received clearance to proceed with clinical studies of lasmiditan (formerly known as COL-144) under IND...

Henry Schein Announces $200 Million Increase to Stock Repurchase Program

August 18, 2011 5:46 am | by Bio-Medicine.Org | News | Comments

MELVILLE, N.Y., Aug. 18, 2011 /- Henry Schein, Inc. (NASDAQ: HSIC ), the largest provider of health care products and services to office-based practitioners, today announced that its Board of Directors has authorized the repurchase of up to $200 million of shares of the Company's common...

AHRA 2011: Debt-weary Feds Eyeing Imaging Cuts

August 18, 2011 5:42 am | by Diagnostic Imaging | News | Comments

Everyone from radiologists to technologists must address upcoming health care changes, as the imaging industry reels from - and faces probable new - cuts in federal funding, said Maggie Sayre, executive director of the Association for Quality Imaging in Washington, D.C.

Chembio Diagnostics' CFO Richard J. Larkin Among the Recipients of "2011 CFO of the Year" Award from Long Island Business News

August 18, 2011 5:42 am | by Bio-Medicine.Org | News | Comments

MEDFORD, N.Y., Aug. 18, 2011 /- Richard Larkin, Chief Financial Officer of Chembio Diagnostics, Inc. (OTCQB: CEMI) (OTC.BB: CEMI), which develops, manufactures, markets and licenses point-of-care diagnostic tests, is among the recipients of the "2011 CFO of the Year" award from Long...

Winner Medical Granted the COTTON USA Mark

August 18, 2011 3:44 am | by Bio-Medicine.Org | News | Comments

SHENZHEN, China, Aug. 18, 2011 /PRNewswire-Asia/ -- Winner Medical Group Inc. (Nasdaq: WWIN ; "Winner Medical" or the "Company"), a leading manufacturer of medical dressings, medical disposables and non-woven fabric made from 100% natural PurCotton® products in China, proudly...

Automakers Test In-Car Brain Sensors

August 17, 2011 8:46 pm | by Massachusetts Institute of Technology | News | Comments

Manufacturers are testing a brain-wave-sensing system that sounds an alarm when it detects sleepiness.

Syndax scores EU patent for potential cancer therapeutic

August 17, 2011 10:40 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Syndax Pharmaceuticals Inc. has been granted a patent from the European Patent Office for an oral HDAC inhibitor, called entinostat, to treat metastatic breast cancer and advanced non-small cell lung cancer.

Endologix Announces Favorable Markman Ruling in Cook Patent Litigation

August 17, 2011 9:48 am | by Bio-Medicine.Org | News | Comments

IRVINE, Calif., Aug. 17, 2011 /- Endologix, Inc. (Nasdaq: ELGX ), developer and marketer of minimally invasive treatments for aortic disorders, announced today that Judge Tanya Walton Pratt of the United States District Court for the Southern District of Indiana in Indianapolis has issued...

Stryker Orthopaedics Enters into Agreement with OrthoSensor for Intelligent Surgical Platform

August 17, 2011 9:48 am | by Bio-Medicine.Org | News | Comments

MAHWAH, N.J. and SUNRISE, Fla., Aug. 17, 2011 /- Stryker Corporation's Orthopaedics Division and OrthoSensor, Inc., the leader in intelligent orthopaedics, today announced an agreement in which OrthoSensor will provide the OrthoSensor™ Knee Trial, designed for use with Stryker's...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading